<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Thursday March 24th 2022 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2022-03-24" ></link>
<id>urn:uuid:96cf4674-ad74-ea93-7775-3b341c2cc6be</id>
<updated>2026-06-13T10:44:01-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ANTX: KRAUSE KEVIN MICHAEL (O) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532489" ></link>
<id>urn:uuid:ebef2292-0bda-295d-4a48-1d18bd0bae81</id>
<updated>2022-03-24T21:27:56-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: SPIGELMAN MELVIN K (DIR) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532490" ></link>
<id>urn:uuid:bb12e4c4-ba87-cc98-9f28-c3e57a886bc2</id>
<updated>2022-03-24T21:27:24-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: MARTIN PATRICIA A (DIR) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532503" ></link>
<id>urn:uuid:debd86a9-f8e8-ad0b-7952-ad80709c9120</id>
<updated>2022-03-24T21:27:01-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: ZAKRZEWSKI JOSEPH S (DIR) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial Indirect Holdings of 505,880</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532488" ></link>
<id>urn:uuid:2554c319-a8c2-936d-1f8d-bed860ca2f7c</id>
<updated>2022-03-24T21:26:44-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: ECKBURG PAUL (O) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial Direct Holdings of 18,289</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532501" ></link>
<id>urn:uuid:d676abdc-47a7-cddc-4e08-c25aea32dff4</id>
<updated>2022-03-24T21:25:06-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: AZIZ KABEER (DIR) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532502" ></link>
<id>urn:uuid:da72edc5-953d-69c3-fbd6-87bfa01fdeeb</id>
<updated>2022-03-24T21:24:54-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: NAZAK MICHAEL ADRIAN (CAO) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532500" ></link>
<id>urn:uuid:a88d31ab-91b8-2891-3442-75996a6b9504</id>
<updated>2022-03-24T21:23:38-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: RA CAPITAL MANAGEMENT L P (BO) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532498" ></link>
<id>urn:uuid:d14ff282-3484-6e8d-4646-8c73f33d0d57</id>
<updated>2022-03-24T21:22:21-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: MARKS GILBERT LYNN (DIR) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial Direct Holdings of 22,830</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532499" ></link>
<id>urn:uuid:2aa5a734-990d-0a94-06c0-41fb46552715</id>
<updated>2022-03-24T21:22:18-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-5532497" ></link>
<id>urn:uuid:d87f8048-0dd3-1f82-ac9c-6157babbe0d3</id>
<updated>2022-03-24T21:21:08-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $4.74. Mkt Cap:170.7mm. 10D Vol: 188,660]]></summary>
</entry>
</feed>